Chronic Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Having pain lasting at least three months. 2. Having a certain level of pain intensity in the last week at the screening. 3. Assuming no change in the contents of treatment as usual during the study participation. 4. At least the age of 18 years. 5. Having the ability to read, write, and understand Japanese. 6. Being able to give free and voluntary written consent to participate in this study. 7. Attending the institutions where the present study is being conducted.
Exclusion criteria
Exclusion criteria: 1. Receiving other psychotherapies. 2. Having experience of receiving hypnosis to treat pain. 3. Receiving or planning to start medical examination or treatment beyond the scope of the treatment as usual during the present study. 4. Having litigation about pain problems. 5. Having a diagnosis of cancer. 6. Having severe cognitive impairment. 7. Having psychiatric problems that would interfere with the study participation currently or within the last 6 months. 8. Being pregnant or having the possibility of being pregnant. 9. Having experience of adverse events by hypnotic induction, or indicating adverse events to hypnotic induction in the present, such as severe symptom aggravation or distress. 10. For any other reason deemed inappropriate by the medical doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of tele-group hypnosis We evaluated the feasibility based on the following three points. 1. Recruitment rate of participants 2. Retention rate of participants 3. Engagement rate for the trial treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in average pain intensity in the last week from the pre- to post-interventions. Change in worst pain intensity in the last week from the pre- to post-interventions. Change in pain interference from the pre- to post-interventions. Change in depression from the pre- to post-interventions. Change in anxiety from the pre- to post-interventions. Change in stress from the pre- to post-interventions. Change in insomnia from the pre- to post-interventions. Change in behavioral inhibition system from the pre- to post-interventions. Change in behavioral activation system from the pre- to post-interventions. Change in pain catastrophizing from the pre- to post-interventions. Change in pain self-efficacy from the pre- to post-interventions. Responsiveness assessed by the decrease in average pain intensity in the last week. Responsiveness assessed by the decrease in worst pain intensity in the last week. Acceptability of intervention (assessed by the semi-structured interview at the post-intervention time point). Change in pain intensity from pre- to post-session. Topological feature changes in correlations of subjective symptoms (anxiety/depression, pain, pain catastrophizing, pain self-efficacy) as measured by the Ecological Momentary Assessment at the pre-and post-interventions. Change in sleep index (sleep duration, sleep latency, sleep efficiency, and number of awakenings during sleep) from the pre- to post-interventions. Change in activity from the pre- to post-interventions. Change in circadian rhythm from the pre- to post-interventions. Change in heart rate from the pre- to post-interventions. Homework engagement rate during the trial treatment phase. Occurrence of adverse events during the observation period. | — |
Countries
Japan
Contacts
Kobe University Graduate School of Human Development and Environment